In fact, recent report showed that activation of JNK in noncancerous liver tissue predicted a high risk of HCC recurrence after surgical resection, suggesting that testing JNK activation in the liver might be useful for the risk assessment of HCC occurrence or recurrence [131]. Here, MAPK8 is linked to hepatocellular carcinoma.